Loading company
Just reported
Q3 2026 results
From LifeStance Health's results release of November 5, 2026; its quarterly report has since been filed.
Revenue
Actual
$455.9M
+25% y/y
+4.7% q/qGuided
$430M
midpoint
Above guide+6.0%Operating income, GAAP
Actual
$33.1M
+346% y/y
+7.9% q/qGuided
—
No guide given
Company outlook
Q4 2026
- Revenue$446M – $466M+19% y/y First given
Full year 2026
- Revenue$1.741B – $1.761B+23% y/y Raised +2.7%
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes LifeStance Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.$22.8BA+
EHCEncompass Health Corporation$13.8BA+
ENSGEnsign Group, Inc.$10.9BA
PACSPACS Group, Inc.$7.6BA
CONConcentra Group Holdings Parent, Inc.$5.4BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A
EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
BIIBBiogen Inc.Oct 28, 2026BAGraded B, now A
Built from LifeStance Health Group, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
